Banned substance furazolidone (AOZ) detected in shrimp at French border
Banned substance furazolidone (AOZ) detected in shrimp at French border
14 April 2021: Banned substance furazolidone (AOZ) detected in shrimp at French border
As per an alert through RASFF – the Rapid Alert System for Food and Feed for the EU, shrimp imported from India has been rejected at the French border in March 2021 for containing a banned substance, known as furazolidone (AOZ). The shrimp product has since been destroyed and did not make it into the market for distribution.
Nitrofuran antibiotics, the parent compound of AOZ, were banned for use in animal food production in the EU in 1995 and 2009 in the US for its reported carcinogenic and mutagenic characteristics. However due to the drugs low cost and effectiveness in controlling disease it is still in use despite the ban.
Randox Food Diagnostics
Randox Food Diagnostics have developed a highly accurate and reliable immunoassay array which detects Nitrofuran residues including AOZ, AMOZ, AHD and SEM.
Available on the Evidence Investigator, our Antimicrobial Array III utilises our patented Biochip Array Technology which provides screening of up to 54 meat and seafood samples. The Evidence Investigator provides results for multiple drug residues and toxins in just 2.5 hours, saving the user both time and money compared to other screening and confirmatory methods.
Randox Food Diagnostics also provide a vast variety of ELISA kits to test for antibiotics in meat and seafood tissue, offering excellent cross-reactivity and unrivalled limits of detection. With results providing great correlation with confirmatory methods, we ensure that better science means safer food.
Want to know more?
For more information on tissue screening methods from Randox Food Diagnostics please visit the links below.
www.randoxfood.com/meat-and-seafood-analysis/
Alternatively contact us via email: info@randoxfooddiagnostics.com
Want to know more?
Contact us or visit our Randox Food Diagnostics website.
Related Products
Meat & Seafood
Milk
Honey
Wine
Randox Covid-19 PCR Tests Reduced to £60 for Overseas Travel
Tuesday 13th April 2021
Randox Covid-19 PCR Tests Reduced to £60 for Overseas Travel
Randox, the UK’s largest Covid-19 PCR testing provider, today announced their support for UK holidaymakers seeking trips overseas by reducing the cost of PCR tests to support travel to £60 per test. Currently PCR tests can cost from £100 each, and often much more.
This announcement comes hot on the heels of the Department for Transport’s plans to open-up overseas travel, potentially from as early as 17th May, but dependent on PCR testing pre-departure and on return. Specific PCR testing requirements will be based on the grading of destination countries within a green, amber and red traffic light system.
Last week UK transport secretary Grant Shapps sought to lower the cost of coronavirus testing to help encourage foreign holidays this summer – and Randox have led the response.
Dr Peter FitzGerald, Randox Managing Director said;
“In recognition of the needs of both the travel industry and the British public at this unprecedented time, Randox will reduce the all-inclusive cost of PCR testing for those in the UK undertaking international travel to £60 per test. We can see the pressures faced by the both the travel industry and the general public and are committed to effective and economical testing to support holidaymakers and those undertaking international travel.
The £60 PCR test is based on a testing kit ordered, on-line, for home sample collection with the sample returned to the laboratory for testing. The cost is inclusive of VAT and logistics. In order to achieve the £60 price, which is limited to those undertaking international travel, purchasers will need to apply a discount code which can initially be obtained from airlines when booking travel.
Those passengers wishing to order a Randox PCR COVID-19 home test should visit: https://www.randoxhealth.com/covid-19-home-testing-kit/
Randox have been active in Covid-19 testing since early 2020, and currently have the largest Covid-19 testing network within the UK.
Background Notes
The Department of Transport report, produced by the Global Travel Taskforce and released on 9th April, shows how international travel could resume from 17 May 2021 at the earliest, in an accessible and affordable way. This includes the removal of the permission to travel form – meaning passengers would no longer need to prove they have a valid reason to leave the country.
The UK is a global leader in genome sequencing, which in positive cases allows the identification of variants of concern.
The risks posed by these variants remain significant, and restrictions for inbound passengers, such as 10-day managed quarantine, home quarantine, and stringent testing will remain in place – but will apply to people differently depending on whether the destination visited is categorised as ‘green’, ‘amber’ or ‘red’.
Green: arrivals will need to take a pre-departure test as well as a polymerase chain reaction (PCR) test on or before day 2 of their arrival back into the UK – but will not need to quarantine on return (unless they receive a positive result) or take any additional tests, halving the cost of tests on their return from holiday
Amber: arrivals will need to quarantine for a period of 10 days and take a pre-departure test, and a PCR test on day 2 and day 8 with the option for Test to Release on day 5 to end self-isolation early
Red: arrivals will be subject to restrictions currently in place for ‘red list’ countries which include a 10-day stay in a managed quarantine hotel, pre-departure testing and PCR testing on day 2 and 8
Testing remains an essential part of protecting public health as restrictions begin to ease – with all arrivals who are not exempt required to book a pre-departure, day 2 and day 8 test before travelling.
For further information on our £60 PCR test please contact the Randox Covid Customer Support team on covidcustomersupport@randox.com or 0800 2545 201.
For press enquiries please contact Amy Millar in the Randox PR team on amy.millar@randox.com or 028 9442 2413
Randox in the media
Latest News
FAQs
Rachael Blackmore wins the Randox Grand National on Minella Times
Saturday 10th April 2021: Rachael Blackmore wins the Randox Grand National 2021 on Minella Times
Rachael Blackmore made history when she became the first female jockey to win the Randox Grand National, on Saturday 10th April 2021.
Upon Henry de Bromhead-trained Minella Times, owned by JP McManus, the odds of a victory for Rachael were 11-1.
Blackmore and Minella Times rode over 30 fences and were first past the post in the 2021 running of the world’s greatest and most famous horse race, beating Balko Des Flos, who finished second, by six and a half lengths.
“I just cannot believe it,” Rachael said.
“I don’t feel male or female right now, I don’t even feel human!”
Unfortunately there were no crowds at Aintree racecourse this year, in light of restrictions relating to the Covid-19 pandemic, but Blackmore was cheered on by owners, trainers, stable staff and racing officials.
An audience of 8.8 million tuned in to ITV to watch Rachael’s historic win onboard Minella Times.
Dickon White, Regional Director for Jockey Club Racecourses said;
“Minella Times, Rachael Blackmore and Henry d Bromhead have given us a story for the ages and I’m grateful that ITV have helped to ensure it inspires people across our society that it doesn’t matter who you are or where you’re from, if you have a dream you should go for it.”
To mark Rachael’s historic win in the Randox Grand National, Randox Health are offering 20% off all health check programmes, until Sunday 18th April. Visit randoxhealth.com to find out more.
For further information please email Amy Millar in the Randox PR team on amy.millar@randox.com or 028 9442 2413
Randox in the media
Latest News
FAQs
Randox Grand National 2021 trophy pays tribute to COVID pandemic key workers
Randox Grand National 2021 trophy pays tribute to COVID pandemic key workers
Saturday 3rd April 2021
The headline sponsor of the Randox Grand National has unveiled the trophy for the 2021 event with a tribute to key workers of the COVID-19 pandemic.
Shown to the public for the first time on Saturday 3rd April during ITV Racing’s Opening Show, the 2021 trophy has been designed for the second year by Silversmith Cara Murphy from Northern Ireland.
The unique design of the silver and gold trophy, which includes illustrations of the COVID-19 virus on its base, acknowledges a historic year and the collective efforts of all key workers during this time.
Dr Peter FitzGerald, Randox Managing Director, said;
“It is only fitting that the trophy for the 2021 Randox Grand National recognises the momentous impact COVID-19 has had on all of our lives, and we pay tribute to the incredible dedication and sacrifice of all key workers in fighting the coronavirus.
“In establishing and running the largest throughput COVID-19 laboratory in the UK, Randox staff have stood shoulder to shoulder with our colleagues in the NHS and elsewhere, and we salute their commitment and achievements.
“As we reflect on the year gone by, and importantly, look ahead to the future, it will be vital that we take forward the lessons we have learnt from the pandemic – the importance of early and accurate testing and the role diagnostic technology can play in meeting future health challenges.
“I believe the 2021 Randox Grand National trophy will serve as a reminder of this message, and of the truly important things in life – our friends, our family, and our health.”
In recognition of Randox’s role in the UK National Testing Programme, the 2021 Randox Grand National trophy features an intricate stem made of the DNA double helix that forms the basis of the testing methods used to detect COVID-19.
At the head of the stem is a striking sphere to signify the circle of Randox’s corporate logo that has become synonymous with a blood drop on which so many of the company’s health tests, including those within Randox Health’s world-leading health checks, are conducted.
Silversmith Cara Murphy commented;
“This has been a tough year for everyone and it has been an honour to work with Randox to create the 2021 Randox Grand National trophy to commemorate the incredible and dedicated efforts of Randox staff in the UK’s National COVID-19 Testing Programme.
“Whilst we are unable to meet together in person for the 2021 Randox Grand National, their hard work has played such a key role in bringing us to a more positive place and one step closer to normality.
“In years to come the winner of this year’s trophy will look at the COVID virus engraving on its base and be able to reflect not only on their success in the Randox Grand National, but on the incredible challenges and achievements of these times.”
Another popular element returning for the 2021 Randox Grand National are the team trophies. In their first year as sponsor, Randox introduced the concept of presenting the entire winning team with individual trophies, to celebrate the combined effort that goes in to achieving such a special victory.
For further enquiries please contact Amy Millar in the Randox PR team: amy.millar@randox.com or 028 9442 2413
Randox in the media
Latest News
FAQs
Belfast City Airport Announces Covid Testing Centre with Randox
Belfast City Airport Announces Covid Testing Centre with Randox
29 March 2021
Belfast City Airport Announces Covid Testing Centre with Randox
Belfast City Airport has announced an onsite covid testing centre in partnership with leading global diagnostics firm, Randox, in preparation for the return of its international flights in the coming months.
The centre will offer both PCR tests and antigen (lateral flow) tests and will give passengers access to quick and safe testing.
Judith Davis, Airport Operations Manager at Belfast City Airport, said:
“The PCR and antigen tests are a current requirement for passengers heading to the Netherlands, and with our KLM flights due to recommence over the next month, it is imperative that we have the testing facilities in place to enable those travelling for essential reasons to be able to do so in a convenient manner.
“The testing facilities will also help with forward planning for those who are connecting through major hub airports, such as Manchester and London Heathrow, or travelling to sunshine destinations with our new airline partner, Ryanair, allowing them to take the test before they leave Northern Ireland.”
Belfast City Airport was recently the first airport in Northern Ireland to achieve the ACI’s Airport Health Accreditation for its extensive and thorough health and safety measures, such as sanitising stations throughout the terminal and requiring anyone entering to wear a face covering.
“The safety of our passengers and staff is at the forefront of our operations and those travelling to the Airport can be reassured that stringent measures are in place” Judith concluded.
David Adamson, Regional Manager at Randox Laboratories, said:
“Along the roadmap out of lockdown, testing will remain a key part of the response to COVID-19 – not only to identify cases and prevent further spread, but also to assist with a return to social and economic normality. The Randox Health Travel Centre at Belfast City Airport, providing accurate and cost-effective antigen and gold standard PCR testing, is another positive step towards the normalization of travel.
“We are pleased to be working with the airport to support their enormous efforts to restore public confidence in international travel and to get people back in the air again if and when they are required to do so.”
Work for the test centre is already underway, with H&J Martin Asset Management Services completing the fit out to include a resting area for passengers who have taken their test, and is expected to be completed over the coming weeks.
For further information please contact Amy Millar in the Randox Public Relations team; amy.millar@randox.com or 028 9442 2413
Randox Health offers a range of COVID-19 testing services for fit to fly, test to release, workplace testing or simply for peace of mind.
Order a home sample collection kit, book an appointment at a Randox Health Travel Centre (available in the UK and Ireland) or visit a Randox Mobile Laboratory (located at Heathrow and Liverpool Airports).
COVID-19 antibody testing is available in Randox Health Clinics.
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
Randox is new patron for NI Chamber of Commerce
25th MARCH 2021
Northern Ireland Chamber of Commerce and Industry (NI Chamber) has announced that Randox, the UK and Ireland’s largest diagnostics company, is its newest Patron organisation.
As a new NI Chamber Patron, Randox joins a select group of leading businesses, who lend their support to the development of the region’s economy and business community. The partnership offers mutual benefit and will see Randox experience increased brand exposure among the business community and close association with a leading membership organisation.
Announcing the partnership, Ann McGregor, Chief Executive, NI Chamber said:
“Randox has a long relationship with NI Chamber and I am delighted to announce that the company has decided to strengthen its association with us, by coming on board as a Patron.
“Having the support of one of Northern Ireland’s leading exporters is a real endorsement of the work we do and in particular, the support NI Chamber has provided to companies over the past 12 months. As we continue to help firms in all sectors to restart and grow, we look forward to working with Randox and indeed all of our Patrons.”
Dr Peter FitzGerald, Managing Director of Randox, added:
“We are delighted to be welcomed as a patron of Northern Ireland Chamber of Commerce and Industry. As a leading life science company with global export markets, Randox very much values the contribution of the Chamber – particularly so at a time of significant change related to Brexit and the impact of COVID-19. We are ambitious for the future and see the potential for significant growth, as the importance of diagnostics and preventative healthcare grows. We look forward to working with Ann and the Chamber team as we rise to meet the challenges and seize the opportunities to grow our economy – for the benefit of all our people.”
Established in 1982, Randox is the largest diagnostics company from the UK and Ireland; focusing on the provision of accurate and timely health testing. By identifying risk to health, improving clinical diagnoses and promoting preventative healthcare, Randox technologies are used to achieve better health outcomes whilst reducing the burden on clinical services. The company’s innovative and comprehensive portfolio includes tests for diabetes, Alzheimer’s disease, cancer, stroke and COVID-19. In 2019 Randox manufactured over 4 billion tests, and operated in 145 countries. With over 2000 staff, including more than 450 research scientists and engineers, key facilities are located in Co Antrim and Co Donegal.
Randox joins a list of NI Chamber Patrons which also includes Caterpillar, Danske Bank, DSV, fonaCAB, Investec, Moy Park, Pinsent Masons, Power NI, Queen’s University, Ulster Bank, Ulster Carpets and Ulster University Business School.
For further information please email Amy Millar, Public Relations Team Leader on amy.millar@randox.com or 028 9442 2413
Randox in the media
Latest News
FAQs
Record level of alcohol deaths recorded during COVID-19 pandemic
Record level of alcohol deaths recorded during COVID-19 pandemic
22 March 2021
Deaths caused by alcohol consumption hit a new high during the first nine months of 2020, new figures for England and Wales show.
Between January and September, 5,640 deaths were registered with this cause – an increase of 16% on the same period in 2019. This significant increase has been the highest recorded figure since records began in 2001. The high rates spanned the period during and after the first national COVID-19 lockdown, according to new figures from the Office for National Statistics.
As in past years, rates of male alcohol-specific deaths were twice those seen for women. Experts say the coronavirus pandemic will have had little effect on how the data was gathered and recorded. But it is not clear how much it may have contributed to the deaths.
A spokesman for ONS said:
“Today’s data shows that in the first three quarters of 2020, alcohol-specific deaths in England and Wales reached the highest level since the beginning of our data series, with April to September, during and after the first lockdown, seeing higher rates compared to the same period in previous years.”
“The reasons for this are complex and it will take time before the impact the COVID-19 pandemic has had on alcohol-specific deaths is fully understood.”
Effects of Alcohol
Alcohol’s impact on your body starts from the moment of consumption. While an occasional glass of wine or beer isn’t a cause for concern, the cumulative effects of drinking beer, wine or spirits can take its toll.
Excessive consumption can impact various parts of the body. Effects can range from weakening of the immune and digestive system, to inflammation and sugar level issues.
Our ‘Effects Of’ Series provides a range of educational posters that ca be displayed in workplaces. Click here to view them.
Did you know that alcohol misuse at work can:
Breath Testing in the Workplace
Handheld breathalysers are an ideal device for conducting workplace alcohol testing. Quick and easy testing provides an instant readout of the donor’s breath alcohol measurement. Simply compare the reading to the cutoff defined in your own drug and alcohol testing policy.
Breathalyser devices gauge blood alcohol content (BAC) by measuring deep lung air. This type of testing can accurately determine whether a person has recently consumed alcohol or is currently over the legal or pre-determined limit. Breathalyser calibrations are maintained in accordance with the manufacturers specifications and periodically accuracy checked to ensure results are accurate and reliable.
How Randox Testing Services can help
At Randox Testing Services, we are pleased to offer a range of stand-alone alcohol tests or combinations of tests to meet your needs.
Throughout the COVID-19 pandemic, RTS have continued to provide drug & alcohol testing services. At all times, we have ensured our staff are equipped to provide sensible advice and flexible solutions to drug & alcohol testing.
Whether for use in workplace settings or for use in court proceedings for medico-legal cases, our range of alcohol testing methods will provide you with accurate and reliable results at competitive prices.
For more information on our alcohol testing services, or to request a quote, contact us using any of the below details.
Website: www.randoxtestingservices.com
Email: testingservices@randox.com
Phone: +44 (0) 28 9445 1011
For those who’ve beaten addiction in their own lives Rehab 4 Addiction is a free addiction helpline. Click here.
Want to know more?
Contact us or visit our website to read more.
Randox Quality Control launches new Acusera D-Dimer Controls
Randox Quality Control launches new Acusera D-Dimer Controls
16 March 2021: Randox Quality Control launches new Acusera D-Dimer Controls
Randox Quality Control has launched a new range of Acusera Controls for the accurate and reliable testing of D-Dimer.
Providing a true third-party solution for D-Dimer testing, which is most often used to investigate whether a patient has a blood clotting disorder, this control is manufactured for use on a range of different diagnostic systems.
Designed to provide accurate and reliable patient testing, this control comes in a liquid frozen format and is stable for an impressive 28 days when stored at 2ºC to 8ºC.
Three levels are supplied, spanning the full clinical range and FEU.
Features and Benefits
- Liquid frozen
- 100% human serum
- 2 year shelf life from date of manufacture
- Cut-off level of 500 ng/ml (FEU) for most analysers
- Open vial stability of 28 days at 2°C – 8°C
- Assayed Control
For more information visit https://www.randox.com/d-dimer-internal-quality-control/
QUALITY CONTROL
REAGENTS
RX SERIES
The Impact of Coronavirus on Drug Use in Europe
15 March 2021: Impact of Coronavirus on Drug Use in Europe
The effect of COVID-19 on the consumption of drugs in Europe has been varied depending on the drug type concerned. Overall, 51.6% of participants in a survey have increased their drug or alcohol consumption and 57.3% reported taking drugs more frequently. The main explanations for these inclines are due to boredom and anxiety, likely due to the imposed restrictions of strict lockdown measures.
According to Statista, Cannabis remains to be the most popular drug used within Europe as 27.2% of respondents revealed that they have used the drug in their lifetime compared to only 5.4% using cocaine. Since the COVID-19 pandemic began in March 2020, regular users of Cannabis have increased their usage, however it is important to note that this has only affected 10% of respondents.
There has been a major hold on the party lifestyle with the shut-down of nightclubs and lack of festival events. As well as, a decrease in the supply of readily available drugs on the market resulting from transport restrictions at country borders. This has impacted the usage of recreational drugs such as cocaine, LSD and MDMA which have seen a decline. The Global Drug Survey revealed that 40% of respondents have used these drugs less during the pandemic.
This detrimental trend has resulted in the domestic production of synthetic opioids. There is a very high risk that substitutes such as fentanyl will become more common. This prediction is concerning due to the dangers associated with such drugs leading to addiction and overdoses. For instance, fentanyl compared to heroin is 50 times stronger.
Public Health England has also released a warning relating to the rise in illegally produced prescription drugs sold as benzodiazepines. These cause harmful health issues due to the mix of unsafe and unknown components.
Randox Toxicology
Randox Toxicology are helping to fight drug trafficking by continually investing in new technologies to aid in the rapid and large-scale screening for drugs of abuse. We are world leaders in drug screening solutions with the capability of detecting over 500 drug and drug metabolites using our innovative Biochip Array Technology – the most comprehensive on the drug testing market. Our patented Biochip Array Technology works across a variety of matrices including whole blood, urine, oral fluid, meconium, vitreous humor and hair.
Using our revolutionary Biochip Array Technology, the Evidence MultiSTAT is a fully automated benchtop analyser that enables onsite, simultaneous testing for up to 21 classical, synthetic or prescription drugs from a single sample in under 20 minutes. This quick and highly reliable technology makes it perfect for use in non-laboratory settings for people with no lab experience.
To find out more about our Biochip Array Technology and our Evidence Series range of analysers, visit www.randoxtoxicology.com or email info@randoxtoxicology.com
For those who’ve beaten addiction in their own lives Rehab 4 Addiction is a free addiction helpline. Click here.
Randox Toxicology Products and Services
BIOCHIP
EVIDENCE
ELISA
MATRICES
Want to know more about Randox?
Contact us or visit our homepage to view more.
SARS-CoV-2 (COVID-19) Antigen Testing Pilot Study from Randox Quality Control
SARS-CoV-2 (COVID-19) Antigen Testing Pilot Study
12 March 2020
SARS-CoV-2 (COVID-19) Antigen Testing Pilot Study
Randox, in partnership with QCMD, is pleased to announce a new QCMD EQA pilot study for SARS-CoV-2 (COVID-19) Antigen Testing. This new pilot is designed to evaluate a laboratory’s ability to detect SARS-CoV-2 (COVID-19) antigen and will provide an opportunity to assess performance against an international peer group.
QCMD is a world leading EQA / Proficiency Testing (PT) provider, dedicated to improving the quality of molecular diagnostic assays used in the detection of infectious diseases. With an extensive database of over 2000 participants in over 100 countries, QCMD is one of the largest providers of molecular EQA in the fi eld of infectious disease testing.
Features & Benefits
-
Whole PathogenAvailability of whole pathogen samples containing the entire viral genome, ensures commutability with the majority of commercial assays.
-
Smart-Phone App Results SubmissionResults can be returned via a smart-phone app so that participants using lateral flow devices can provide pictures of their device/result with the phone camera.
-
Comprehensive ReportsA real-time rapid report will be provided on submission of results. An individual report is received after each challenge, summarising laboratory performance in comparison to an international peer group.
-
EQA Management SystemIT EQA Management System (ITEMS) provides an online tool to easily manage all EQA activities from programme registration to submission of results and provision of EQA reports.
-
Not infectiousSamples containing SARS-CoV-2 antigens are inactivated and not infectious ensuring safe handling of material.
-
Suitable for Point of CareSamples are supplied liquid ready-to-use ensuring they are ideal for use at the point care.
For more information visit https://www.randox.com/qcmd-sars-antigen-testing/
For further enquiries please email marketing@randox.com
